Competing Interests statement
Rudolf Valenta has received research grants from the Austrian Science
Fund (FWF), HVD Biotech, Vienna, Austria, Worg Pharmaceuticals,
Hangzhou, China and Viravaxx, Vienna, Austria and serves as a consultant
for Viravaxx. The other authors do not have any conflicts of interest.